Biohaven Pharmaceutical Holding Co. Ltd.
(NYSE: BHVN)
Rigrodsky Law, P.A. is investigating Biohaven Pharmaceutical Holding Co. Ltd. (“Biohaven”) regarding possible breaches of fiduciary duties and other violations of law related to Biohaven’s agreement to be acquired by Pfizer Inc. Under the terms of the agreement, Biohaven’s shareholders will receive $148.50 in cash for each share of Biohaven common stock they own.